SURVEY: As companies return to workplace, testing will take a back seat to multiple safety measures

The industry responsible for bringing testing to the public isn’t relying on it to go back to work.

BioCentury’s survey finds that as biopharma companies begin to reopen their doors to employees, they aren’t going to be relying on viral or antibody testing. Instead, they are expecting employees with symptoms of COVID-19 to recuse themselves, and are planning on multiple measures to establish safe working conditions...